Prescriptions for estrogen replacement therapy in Ontario before and after publication of the Women's Health Initiative Study.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

18 citing papers in PubMed, 2 syntheses or guidelines pooled it, 93 citations in OpenAlex.

1. Printed educational materials: effects on professional practice and healthcare outcomes.The Cochrane database of systematic reviews · 2020
   Pooled it
2. Printed educational materials: effects on professional practice and healthcare outcomes.The Cochrane database of systematic reviews · 2012
   Pooled it
3. Impact of the ENHANCE trial on the use of ezetimibe in the United States and Canada.American heart journal · 2014 · on this map
   Trial
4. No decrease in incidence of arthroscopic meniscectomy in a Canadian province.Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA · 2021
   Article
5. A diet containing high- versus low-daidzein does not affect bone density and osteogenic gene expression in the obese Zucker rat model.Food & function · 2019
   Article
6. Disparities in surgery among patients with intractable epilepsy in a universal health system.Neurology · 2016
   Article
7. Towards understanding the de-adoption of low-value clinical practices: a scoping review.BMC medicine · 2015
   Article
8. Phytoestrogens in postmenopause: the state of the art from a chemical, pharmacological and regulatory perspective.Current medicinal chemistry · 2014
   Review
9. Those who have the gold make the evidence: how the pharmaceutical industry biases the outcomes of clinical trials of medications.Science and engineering ethics · 2012
   Article
10. Cardiovascular disease in kidney donors: matched cohort study.BMJ (Clinical research ed.) · 2012
    Article
11. Statin use associates with a lower incidence of acute kidney injury after major elective surgery.Journal of the American Society of Nephrology : JASN · 2011
    Article
12. Trends in HRT and anti-osteoporosis medication prescribing in a European population after the WHI study.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2008
    Article
13. Osteoporosis practice patterns in 2006 among primary care physicians participating in the NORA study.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2007
    Article
14. Sarcopenia in premenopausal and postmenopausal women with osteopenia, osteoporosis and normal bone mineral density.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2006
    Article
15. The impact of clinical trials on the use of hormone replacement therapy. A population-based study.Journal of general internal medicine · 2005
    Article
16. Evidence from clinical trials: can we do better?NeuroRx : the journal of the American Society for Experimental NeuroTherapeutics · 2004
    Review
17. Impact of female hormones on blood pressure: review of potential mechanisms and clinical studies.Current hypertension reports · 2003
    Review
18. Appraisal of Core Therapy, Supportive Therapy, and Alternative Therapy in a Tertiary Care Rural Hospital of Vidarbha Region in Correlation to Plethora of Menopausal Problems.Journal of mid-life health
    Article

Corrections and comments

• Comment on
  Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group.1998
• Comment on
  Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.2002

Authors and funding

4 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as